BioNexus Gene Lab Corp 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001477932-26-003242
- Form type
- 10-Q
- CIK
- 0001737523
- Primary document
- https://www.sec.gov/Archives/edgar/data/1737523/000147793226003242/bglc_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioNexus Gene Lab Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $22,842 | - | - |
| Cost Of Revenue | $23,632 | - | - |
| Gross Profit | $-790 | - | - |
| Operating Income | $-540,490 | - | - |
| Net Income | $-543,575 | - | - |
| Eps Diluted | -0.225 | - | - |
| Total Assets | $9.0M | - | - |
| Total Liabilities | $946,877 | - | - |
| Shareholders Equity | $8.1M | - | - |
| Operating Cash Flow | $-147,671 | - | - |
| Capital Expenditures | $325 | - | - |